Get Live Data

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Bowleven Share Price
  4. Bowleven Share Regulatory News
  5. Posting of Annual Report and Accounts 2023

Pin to quick picksBowleven Regulatory News (BLVN)

Bowleven Information

Share Price Information for Bowleven (BLVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
BLVN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of Annual Report and Accounts 2023

15 Nov 2023 17:47

RNS Number : 6106T
Bowleven plc
15 November 2023
 

 

 

 

 

15 November 2023

 

 

 

Bowleven plc

('Bowleven' or the 'Company')

 

Posting of Annual Report and Accounts 2023

 

Bowleven announces that its annual report and accounts for the year ended 30 June 2023 ('Report and Accounts'), containing a notice convening the 2023 Annual General Meeting ('AGM'), was posted to shareholders on 15 November 2023.

 

The AGM will be held at 10 a.m. (UK time) on Wednesday, 6 December 2023 at The Office Group, Borough Yards, 13 Dirty Lane, London, SE1 9PA.

 

The Report and Accounts are also available to view on the Company's website at www.bowleven.com/investor-relations/reports-results.

 

 

 

ENQUIRIES

 

For further information, please contact:

Bowleven plc

Eli Chahin, Chief Executive

00 44 203 327 0150

Camarco (Financial PR)

Owen Roberts

Hugo Liddy

00 44 203 757 4980

Shore Capital (NOMAD & Broker)

Robert Finlay

Daniel Bush

Angus Murphy

 

 

00 44 207 408 4090

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSDLELELIV
111213141516171819
Date   Source Headline
17th Jun 20099:18 amRNSHolding(s) in Company
16th Jun 20093:44 pmRNSHolding(s) in Company
15th Jun 200911:17 amRNSHolding(s) in Company
11th Jun 20094:19 pmRNSHolding(s) in Company
11th Jun 20094:18 pmRNSHolding(s) in Company
11th Jun 20094:02 pmRNSDirector/PDMR Shareholding
11th Jun 200911:59 amRNSHolding(s) in Company
9th Jun 200912:32 pmRNSResult of Equity Issue
9th Jun 20097:00 amRNSProposed Placing
4th Jun 200910:28 amRNSHolding(s) in Company
2nd Jun 20095:13 pmRNSHolding(s) in Company
2nd Jun 20095:02 pmRNSHolding(s) in Company
2nd Jun 20094:51 pmRNSHolding(s) in Company
2nd Jun 20094:42 pmRNSHolding(s) in Company
1st Jun 20097:00 amRNSCompetent Person's Report
29th May 20094:31 pmRNSNotification: Release of Competent Person's Report
18th May 200912:48 pmRNSDirector/PDMR Shareholding
13th May 20091:07 pmRNSDirectorate Change
5th May 200910:56 amRNSHolding(s) in Company
5th May 200910:43 amRNSHolding(s) in Company
5th May 200910:34 amRNSHolding(s) in Company
27th Apr 200911:51 amRNSHolding(s) in Company
14th Apr 200910:03 amRNSEPT Disclosure
9th Apr 20096:19 pmRNSHolding(s) in Company
8th Apr 200911:40 amRNSEPT Disclosure
8th Apr 20099:19 amBUSEPT Disclosure
7th Apr 200910:33 amRNSEPT Disclosure
7th Apr 200910:28 amRNSOffer Talks Terminated
7th Apr 20099:46 amBUSEPT Disclosure
6th Apr 200910:19 amRNSEPT Disclosure
6th Apr 20099:35 amBUSEPT Disclosure
3rd Apr 200911:19 amRNSEPT Disclosure
2nd Apr 200910:12 amRNSEPT Disclosure
2nd Apr 20099:10 amBUSEPT Disclosure
1st Apr 200911:38 amRNSEPT Disclosure
1st Apr 20099:29 amBUSEPT Disclosure
31st Mar 200912:26 pmRNSHolding(s) in Company
31st Mar 200910:28 amRNSEPT Disclosure
31st Mar 20099:26 amBUSEPT Disclosure
30th Mar 20092:36 pmRNSRule 8.3- (Bowleven Plc)
30th Mar 200912:35 pmRNSEPT Disclosure
30th Mar 200910:31 amBUSEPT Disclosure
27th Mar 20094:41 pmRNSSecond Price Monitoring Extn
27th Mar 20094:35 pmRNSPrice Monitoring Extension
27th Mar 20094:28 pmRNSStatement re Possible Offer
27th Mar 20092:29 pmRNSRule 8.3- (Bowleven plc)
27th Mar 200911:23 amRNSEPT Disclosure
26th Mar 200911:11 amRNSEPT Disclosure
26th Mar 20099:20 amBUSEPT Disclosure
26th Mar 20098:49 amRNSRule 8.3- Bowleven PLC
111213141516171819

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.